OTC/Supplement Co-Packaging Policy In The Works At FDA
This article was originally published in The Tan Sheet
Any future FDA guidance or regulation on co-packaging OTCs with dietary supplements would have to reflect the agency's resolution of concerns related to duration of use, dual-labeling and multiple claims for such products
You may also be interested in...
FDA should include OTC drug/dietary supplement combinations in its combination products guidelines and place them under the jurisdiction of the Office of Combination Drugs, attorney Ralph Fucetola recommends
House Government Reform Committee Chair Dan Burton (R-Ind.) is pressing FDA to explain its intentions regarding OTC drug/dietary supplement combination products
The presence of acetaminophen in OTC/dietary supplement combination products renders them drugs, FDA says in recent warning letters to two companies.